Rocket One Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Rocket One Inc. (RKTO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 170.00 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-27
- Rocket One Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- Rocket One Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- Rocket One Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 0.00 shares.
- Rocket One Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 170.00K shares.
- Rocket One Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 170.00K shares, a 81.58% decline from fiscal 2024.
- Rocket One Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 923.00K shares.
- Rocket One Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 5.08K shares, a 26.88% increase from fiscal 2021.
- Rocket One Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 4.00K shares, a 39.99% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-27 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-27 | 170.00K shares 10-K · filed 2026-03-27 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-12 | 170.00K shares 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 170.00K shares 10-Q · filed 2025-08-12 | |||
| 2025-03-31 | 170.00K shares 10-Q · filed 2025-05-12 | ||||
| 2024-12-31 | 923.00K shares 10-K · filed 2026-03-27 | ||||
| 2022-12-31 | 5.08K shares 10-K · filed 2024-03-28 | ||||
| 2021-12-31 | -96.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -628.00K shares derived: sum of 2 quarters · filed 2023-03-31 | -628.00K shares derived: sum of 3 quarters · filed 2023-03-31 | 4.00K shares 10-K · filed 2023-03-31 | 100.00K shares 10-K · filed 2022-03-30 |
| 2021-09-30 | -532.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -532.00K shares derived: sum of 2 quarters · filed 2021-11-10 | 100.00K shares 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | 632.00K shares 10-Q · filed 2021-08-11 | |||
| 2021-03-31 | 632.00K shares 10-Q · filed 2021-05-13 | ||||
| 2020-12-31 | 6.67K shares 10-K · filed 2022-03-30 | 200.00K shares 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |